CTOs on the Move

Presbyterian/St. Luke`s Medical Center

www.pslmc.com

 
Presbyterian/St. Luke’s Medical Center’s history dates back to 1881 with many “firsts” in healthcare over the years. In 1993, P/SL opened the first cancer center in the Rocky Mountain region, and one of the first centers of its kind in the U.S., dedicated exclusively to the treatment of cancer. P/SL now has the largest bone marrow transplant center in the region, The Colorado Blood Cancer Institute (CBCI). CBCI is nationally recognized for the clinical expertise and research of its eight physicians who have more than 140 years of cumulative experience. In 2013, CBCI performed more than 250 bone marrow transplants.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.pslmc.com
  • 1719 E 19th Ave.
    Denver, CO USA 80218
  • Phone: 303.839.6000

Executives

Name Title Contact Details

Similar Companies

Goshen Medical Center

Goshen Medical Center is a Faison, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Peconic Bay Medical Center

Peconic Bay Medical Center is a Riverhead, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Deborah Heart and Lung Center

Deborah Heart and Lung Center is a 89-bed teaching hospital that specializes in the diagnosis and treatment of congenital and acquired heart, lung and vascular diseases in adults, as well as providing outpatient cardiology services for children. Equal opportunity provider.

MercyOne North Iowa Medical Center

We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life. MercyOne is the largest health care system in Iowa. We continue under the latest agreement between Trinity Health and CommonSpirit Health, two of the nation`s largest not-for-profit health systems.

Signal Genetics

Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.